Lonza to acquire Genentech’s biologics manufacturing facility in Vacaville for $1.2bn
In a strategic move that significantly escalates its capacity in the biologics manufacturing landscape, Lonza, a key global player in manufacturing for the pharmaceutical, biotech, and nutraceutical markets, announced its acquisition of Genentech’s large-scale biologics manufacturing facility in Vacaville, California, from Roche for USD 1.2 billion. This acquisition marks a significant expansion of Lonza’s manufacturing […]